Market Overview

Therapeutic Drug Monitoring Market, 2023 by Product (Consumable, Equipment), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End User - ResearchAndMarkets.com

Share:

The "Therapeutic
Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay
analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay,
GCMS), Class of drugs (Antibiotics, Bronchodilators), End User - Global
Forecast to 2023"
report has been added to ResearchAndMarkets.com's
offering.

The therapeutic drug monitoring market is expected to reach USD 1.63
billion by 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9% during
the forecast period.

The growth of this market is majorly driven by the rising number of
organ transplant procedures and the use of TDM in traditional anticancer
therapies. However, the lack of financial provisions for the clinical
interpretation of TDM results is expected to restrain the growth of this
market during the forecast period.

On the basis of end user, the therapeutic drug monitoring market is
divided into hospital laboratories, commercial/private laboratories, and
other end users. In 2018, the hospital laboratories segment is expected
to account for the largest share of the therapeutic drug monitoring
market. The large share of this segment is attributed to the fact that
most diagnostic tests are performed in hospitals or hospital-attached
laboratories as they have the appropriate equipment as well as skilled
staff to deliver clinically meaningful interpretations from TDM assays.
Compared to reference laboratories, hospital laboratories are also more
accessible and offer faster results.

On the basis of products, the TDM market is segmented into consumables
and equipment. In 2018, the consumables segment is expected to account
for a larger share of this market owing to the requirement of repeat
purchase of kits and reagents, coupled with the increasing number of
immunoassay tests being performed across the globe as a result of the
rising incidence of chronic and infectious diseases.

On the basis of class of drugs, the TDM market is segmented into
antiepileptic drugs, antibiotic drugs, immunosuppressant drugs,
antiarrhythmic drugs, bronchodilator drugs, psychoactive agents, and
other drugs. In 2018, the antiepileptic drugs segment is expected to
account for the largest share of the market. Antiepileptics are the most
commonly monitored class of drugs due to the high complexity and
heterogeneity of epilepsy, lack of biological markers or specific
clinical signs aside from the frequency of seizures to assess treatment
efficacy or toxicity, and the highly complex pharmacokinetics of these
drugs.

On the basis of technology, the therapeutic drug monitoring market is
classified into immunoassays and chromatography-MS. The immunoassays
segment is expected to account for the largest share of this market in
2018, mainly due to the increasing incidence of chronic and infectious
diseases and technological innovation.

By region, North America is expected to account for the largest share of
the TDM market in 2018, followed by Europe. The dominant share of the
North American market is primarily due to its well-established
pharmaceutical industry, favorable government funding, and high R&D
investments in this region.

The key players operating in the TDM market are F. Hoffmann-La Roche
(Switzerland), Siemens Healthineers (Germany), and Abbott (US).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Therapeutic Drug Monitoring Market, By Product

7 Therapeutic Drug Monitoring Market, By Technology

8 Therapeutic Drug Monitoring Market, By Class of Drug

9 Therapeutic Drug Monitoring Market, By End User

10 Therapeutic Drug Monitoring Market, By Region

11 Competitive Landscape

12 Company Profiles

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Biomrieux
  • Bhlmann Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche
  • Randox Laboratories
  • Sekisui Medical
  • Siemens Healthineers
  • Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/hwlclw/therapeutic_drug?w=4

View Comments and Join the Discussion!